Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.67
$0.011.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.58% | 37.97% | -82.48% | -76.37% | 2.56% |
| Total Depreciation and Amortization | 15,961.11% | 25.00% | -200.00% | -47.37% | -10.00% |
| Total Amortization of Deferred Charges | -- | -92.64% | -93.95% | -98.54% | -100.00% |
| Total Other Non-Cash Items | 615.45% | -68.94% | -202.41% | 148,850.00% | -134.20% |
| Change in Net Operating Assets | 158.31% | -147.03% | 1,203.64% | -274.89% | -641.84% |
| Cash from Operations | 63.83% | -31.43% | -139.77% | -103.93% | -153.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 81.08% | 87.36% | -- | 82.15% |
| Issuance of Common Stock | -43.29% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 101.59% | 69.32% | -1,040.25% | -471.75% | -- |
| Cash from Financing | -49.05% | 51.02% | 892.74% | 12,898.50% | 1,431.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.84% | -405.29% | 143.40% | 320.11% | 234.66% |